Lataa...
Lung cancer, elderly and immune checkpoint inhibitors
Lung cancer is predominantly a disease of the elderly with about 50% of diagnoses in patients aged ≥70 years and about 14% in those older than 80. Medical and physiological characteristics of elderly cancer patients make the choice of their better treatment more challenging. Furthermore, aging is ac...
Tallennettuna:
| Julkaisussa: | J Thorac Dis |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5994497/ https://ncbi.nlm.nih.gov/pubmed/29951299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.05.90 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|